InsiderTrades.com logo

IMDX Insider Trading

Insider Ownership Percentage: 2.05%
Insider Buying (Last 12 Months): $2,999,999.25
Insider Selling (Last 12 Months): $0.00

Oncocyte Insider Trading History Chart

This chart shows the insider buying and selling history at Oncocyte by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Oncocyte Share Price & Price History

Current Price: $5.58
Price Change: ▼ Price Decrease of -0.15 (-2.62%)
As of 02/12/2026 05:00 PM ET

This chart shows the closing price history over time for IMDX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Oncocyte Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/10/2026Broadwood Partners, L.P.Major ShareholderBuy521,739$5.75$2,999,999.2511,931,839View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Oncocyte (NASDAQ:IMDX)

55.35% of Oncocyte stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Oncocyte logo
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.
Read More on Oncocyte

Today's Range

Now: $5.58
Low: $5.22
High: $5.70

50 Day Range

MA: $6.38
Low: $4.76
High: $7.50

52 Week Range

Now: $5.58
Low: $2.21
High: $8.51

Volume

124,714 shs

Average Volume

47,703 shs

Market Capitalization

$159.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.35

Who are the company insiders with the largest holdings of Oncocyte?

Oncocyte's top insider investors include:
  1. Broadwood Partners, LP (Major Shareholder)
Learn More about top insider investors at Oncocyte.